Delic Looks to Build a Sprawling ‘Psychedelic Ecosystem’
January 20th, 2021
App, Exclusive, Psychedelics, Top Story
There have been a number of high profile initial public offerings in the psychedelic space, including COMPASS Pathways’ (NASDAQ: CMPS) $2 billion debut. While there are now more than 30 publicly traded companies in the space, there are thousands more private companies at various stages of funding and development.
Delic Corp. (CSE: DELC) (OTCQB: DELCF) was founded by former High Times executives to cultivate these companies through a combination of awareness and capital. With three existing platforms reaching over 300,000 people per month, the company is already making inroads and educating the public while planning a flagship in-person event for 2021.
Massive & Growing Market
Psychedelics have captured the attention of researchers after a series of promising early-stage clinical trials. In fact, the FDA has already approved ketamine nasal spray as a treatment for suicidal behavior and granted Breakthrough Therapy status to at least two psilocybin-based treatments for mental health disorders, like treatment-resistant depression.
Psychedelic Keyword Trends for ‘psilocybin’ – Source: Google Trends
Of course, the therapeutic potential for psychedelics is just scratching the surface of a larger revolution among consumers. More than 30 million American adults have tried psychedelics at least once in their life and psychedelic substances could be transformative for everything from enhancing creativity to dealing with past traumas in counseling sessions.
A Unique Business Model
Delic’s team is front and center in the psychedelic space, which enables them to see the best deals. Co-Founders Jackee and Matt Stang were executives at High Times before shifting their focus to psychedelics. In addition, the company’s board of directors includes names like Paul Rosen, Kraig Fox, Martin Tobias and Sashko Despotovski.
Recently, the company announced that Shep Gordon would join its advisory board. Mr. Gordon is an American talent manager, Hollywood film agent and producer that has advised countless businesses across different industries and will leverage his wealth of experience to help DELIC realize its ambitions in the psychedelics space.
Delic’s Executive Team – Source: Investor Presentation
It’s no secret that the psychedelics industry has attracted significant levels of capital as it targets a massive market opportunity. ATAI Life Sciences closed a $125 million Series C round, COMPASS Pathways raised $127.5 million in its going public transaction and MindMed Inc. raised C$80 million a recent bought deal—and these trends are poised to accelerate.
Leveraging its high-profile team, media platform and capital, the company’s private equity model will focus on acquiring nimble, cash flowing and scalable psychedelic companies before they reach the masses through venture capital or a public listing. These dynamics provide shareholders with diversified access to some of the industry’s best opportunities.
More than a Media Empire
The psychedelics industry remains in the early stages of growth. Like the cannabis industry in 2006, the psychedelics industry presents investors with a unique opportunity to get involved at an early stage before it goes mainstream. Media companies could become key gatekeepers within the industry and have early access to relationships and dealflow.
Delic’s Reality Sandwich brand already reaches more than 300,000 people each month and is top ranked for high-profile Google keywords. In addition to an online presence, the company’s Meet Delic event will bring together mind-state technology vendors, industry experts and thought leaders to create one of the industry’s biggest events.
Moving forward, the company plans to make additional acquisitions in the psychedelics industry beyond media brands and events, leveraging its status as a publicly traded psychedelic wellness corporation. With a low float and DTC eligibility around the corner, the company should have ample access to capital to grow over the coming quarters.
Delic Corp. (CSE: DELC) (OTCQB: DELCF) is uniquely positioned as a leading voice in the nascent psychedelics industry. With growing interest among investors, the company aims to leverage its presence to unlock value through private equity deals and build a sprawling psychedelic ecosystem.
The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.